Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study.
作者信息
Ettinger D S, Finkelstein D M, Harper G R, Ruckdeschel J C, Chang A Y, Camacho F J, Marsh J C, Silber R, Wolter J M